Insider · CIK 0001514980
Brian Mueller
Files at BMRN (BIOMARIN PHARMACEUTICAL INC). First filing -, latest -.
In brief
Brian Mueller files SEC Form 4 as CFO at BMRN (BIOMARIN PHARMACEUTICAL INC). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Brian Mueller has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 13 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Mar 17, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | FTax withholding Common Stock | -2,117 | $56.05 | $119k | 123,314 | Mar 19, 2026 |
| Mar 13, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | FTax withholding Common Stock | -9,945 | $58.51 | $582k | 106,691 | Mar 17, 2026 |
| Mar 16, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +18,740 | $0.00 | $0 | 125,431 | Mar 17, 2026 |
| Mar 16, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Stock Option (Right to Buy Common Stock)derivative | +44,600 | $0.00 | $0 | 44,600 | Mar 17, 2026 |
| Feb 25, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +6,683 | $0.00 | $0 | 106,839 | Feb 26, 2026 |
| Feb 25, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +7,230 | $0.00 | $0 | 114,069 | Feb 26, 2026 |
| Feb 25, 2026 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +2,569 | $0.00 | $0 | 116,638 | Feb 26, 2026 |
| Mar 14, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | FTax withholding Common Stock | -18,497 | $69.44 | $1.3M | 83,141 | Mar 18, 2025 |
| Mar 17, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +16,640 | $0.00 | $0 | 99,781 | Mar 18, 2025 |
| Mar 17, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Stock Option (Right to Buy Common Stock)derivative | +38,590 | $0.00 | $0 | 38,590 | Mar 18, 2025 |
| Feb 25, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +11,040 | $0.00 | $0 | 82,611 | Feb 27, 2025 |
| Feb 25, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +9,660 | $0.00 | $0 | 92,271 | Feb 27, 2025 |
| Feb 25, 2025 | BMRN BIOMARIN PHARMACEUTICAL INC | AGrant or award Common Stock | +9,367 | $0.00 | $0 | 101,638 | Feb 27, 2025 |
Questions about Brian Mueller
Answered from the filings on this page, as of the latest one.
Is Brian Mueller buying or selling?
Brian Mueller has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Brian Mueller's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Brian Mueller has 0.
Where does Brian Mueller file Form 4?
Brian Mueller has filed Form 4 at BMRN (BIOMARIN PHARMACEUTICAL INC) as EVP, Chief Financial Officer. A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.